Author

Svetlana S. Efimova

Russian Academy of SciencesORCID 0000-0002-2429-2007Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biophysics· 1 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2

Frequent Co-Authors

Olga S. OstroumovaiD· 3 shared Egor V. ShekunoviD· 2 shared Alexander V. SlitaiD· 1 shared Andrey Egorovich ShchekotikhiniD· 1 shared Anna A. Muryleva· 1 shared Anna I. MalykhinaiD· 1 shared Anna N. TevyashovaiD· 1 shared Ekaterina V. Vodopyanova· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Olga S. OstroumovaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Echinocandins have an alternative mode of action on biomimetic membranes that is not directly related to the functioning of (1,3) beta-glucan synthase

Anna I. Malykhina, Svetlana S. Efimova, Ekaterina V. Vodopyanova, Natalia E. Grammatikova, Anna N. Tevyashova, Andrey Egorovich Shchekotikhin, Olga S. Ostroumova

This study shows echinocandins form ion-permeable pores in sterol-containing membranes, altering lipid microenvironment and membrane permeability, independent of (1,3) beta-glucan synthase inhibition.

Cell Death Discovery · Apr 28, 2026Peer-reviewedMicrobiology

Lipid specificity of action of SARS-CoV-2 fusion peptide fragments on model membranes

Egor V. Shekunov, Pavel E. Volynsky, Svetlana S. Efimova, Elena T. Aliper, Roman G. Efremov, Olga S. Ostroumova

This study investigates how SARS-CoV-2 fusion peptide fragments interact with model membranes, showing the LLF motif's role in membrane fusion and how lipid composition affects fusogenic activity.

bioRxiv · Dec 11, 2024 · PreprintBiophysics

Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: new tricks for old dogs

Egor V. Shekunov, Polina D. Zlodeeva, Svetlana S. Efimova, Anna A. Muryleva, Vladimir V. Zarubaev, Alexander V. Slita, Olga S. Ostroumova

The paper investigates the antiviral effects of cyclic lipopeptides against SARS-CoV-2 by assessing their ability to inhibit membrane fusion in vitro.

Antiviral Research · Mar 2, 2023Peer-reviewedMolecular Biology